That is quite an interesting quote. So, the deal to fund the Phase III study was supposed to come after having received "clearance?" I believe we received that clearance - many months ago actually, overlooking the Ethics Clearance we received last month, if I am recalling correctly. I wonder what is happening with the deal that the clearance is said to be the requirement for funding the trial phase. This quote is from last year. That is a long time ago.
Right now, it appears there are more reasons to be cautious than to go all in. I do not like that.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
-0.015(4.48%) |
Mkt cap ! $124.6M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.0¢ | 31.5¢ | $215.7K | 663.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 30081 | 31.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 10905 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| PAR (ASX) Chart |